Registered Kenya · PPB

CATAFLAM 1.8MG/ML SUSPENSION

CATAFLAM ORAL SUSPENSION

H2014/CTD1015/157 1.8MG/ML dermatologicals

What it does

Cataflam is a medication used to relieve pain and reduce inflammation.

Commonly used for: pain relief, inflammation, arthritic conditions, menstrual pain

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2014/CTD1015/157
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CATAFLAM ORAL SUSPENSION
Dosage form
1.8MG/ML
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
D11AX - Other dermatologicals
Drug group
DERMATOLOGICALS
RxNorm RxCUI
215916
Manufacturer / MAH
Nvs Kenya
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Mogadishu Road, off Lunga Lunga Road, Industrial Area, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:53:35 · updated 2026-07-26 11:44:13

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Cataflam is a medication used to relieve pain and reduce inflammation.

What it treats

  • pain relief
  • inflammation
  • arthritic conditions
  • menstrual pain

How it works

Cataflam works by blocking substances in the body that cause pain and inflammation.

Who it's for

It is suitable for adults and children who need relief from pain or inflammation.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: cataflam

BNF-referenced

Cataflam is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to relieve pain and inflammation. It is the potassium salt of diclofenac and is indicated for various conditions including arthritis, menstrual pain, and postoperative pain. Its anti-inflammatory properties make it effective in managing conditions associated with pain and inflammation.

Indications

  • Osteoarthritis
  • Rheumatoid arthritis
  • Acute musculoskeletal pain
  • Dysmenorrhea
  • Postoperative pain
  • Gout attacks

Dosage

Children: For children aged 1 to 12 years, the dose is generally based on weight. Refer to BNF for Children for specific dosing recommendations.

Adults: The usual oral dose for adults is 50 mg taken two or three times daily, depending on the severity of symptoms.

Mechanism of action

Cataflam works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the conversion of arachidonic acid to prostaglandins. Prostaglandins are mediators of inflammation and pain. By decreasing their production, Cataflam effectively reduces pain, inflammation, and fever.

Pharmacodynamics

The pharmacodynamic effects of Cataflam include a reduction in the synthesis of prostaglandins, leading to decreased inflammatory responses and alleviation of pain. It exhibits analgesic, antipyretic, and anti-inflammatory effects. The onset of action typically occurs within a few hours, providing quick relief for acute pain conditions.

Pharmacokinetics

Cataflam is rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1 to 2 hours. It is extensively metabolized in the liver, mainly through glucuronidation and oxidation. The elimination half-life ranges from 1 to 2 hours, with metabolites excreted primarily in urine. The drug's bioavailability is approximately 50% due to first-pass metabolism.

Contra-indications

  • Active or history of peptic ulcer disease
  • Severe heart failure
  • Severe hepatic impairment
  • Severe renal impairment
  • Known hypersensitivity to diclofenac or any of the excipients

Adverse effects

  • Gastrointestinal bleeding
  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Headache
  • Dizziness
  • Rash
  • Elevated liver enzymes
  • Kidney impairment

Interactions

  • Anticoagulants may enhance the risk of bleeding
  • Other NSAIDs may increase the risk of adverse effects
  • Diuretics may reduce effectiveness
  • ACE inhibitors may have decreased effectiveness
  • Methotrexate may have increased toxicity

Precautions

  • Monitor renal function in patients with renal impairment
  • Use with caution in patients with a history of gastrointestinal disease
  • Avoid in patients with cardiovascular disease
  • Caution in elderly patients due to increased risk of adverse effects

Pregnancy

Use during pregnancy, especially in the third trimester, is contraindicated as it may cause fetal harm or complications during delivery.

Breast-feeding

Diclofenac is excreted in breast milk, and caution is advised when used during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Tablets
  • Topical gel
  • Injection solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: cataflam

PubChem CID 23667642

Molecular formula: C14H10Cl2KNO2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.